Reto Kaderli1, Beat Schnüriger, Lukas E Brügger. 1. Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, 3010, Bern, Switzerland, reto.kaderli@insel.ch.
Abstract
PURPOSE: The worldwide prevalence of human papillomavirus (HPV) infection is estimated at 9-13 %. Persistent infection can lead to the development of malignant and nonmalignant diseases. Low-risk HPV types are mostly associated with benign lesions such as anogenital warts. In the present systematic review, we examined the impact of smoking on HPV infection and the development of anogenital warts, respectively. METHODS: A systematic literature search was performed using MEDLINE database for peer-reviewed articles published from January 01, 1985 to November 30, 2013. Pooled rates of HPV prevalence were compared using the χ (2) test. RESULTS: In both genders, smoking is associated with higher incidence and prevalence rates for HPV infection, whereas the latter responds to a dose-effect relationship. The overall HPV prevalence for smoking patients was 48.2 versus 37. 5 % for nonsmoking patients (p < 0.001) (odds ratio (OR) = 1.5, 95 % confidence interval (CI) 1.4-1.7). Smoking does also increase persistence rates for high-risk HPV infection, while this correlation is debatable for low-risk HPV. The incidence and recurrence rates of anogenital warts are significantly increased in smokers. CONCLUSIONS: Most current data demonstrate an association between smoking, increased anogenital HPV infection, and development of anogenital warts. These data add to the long list of reasons for making smoking cessation a keystone of patient health.
PURPOSE: The worldwide prevalence of human papillomavirus (HPV) infection is estimated at 9-13 %. Persistent infection can lead to the development of malignant and nonmalignant diseases. Low-risk HPV types are mostly associated with benign lesions such as anogenital warts. In the present systematic review, we examined the impact of smoking on HPV infection and the development of anogenital warts, respectively. METHODS: A systematic literature search was performed using MEDLINE database for peer-reviewed articles published from January 01, 1985 to November 30, 2013. Pooled rates of HPV prevalence were compared using the χ (2) test. RESULTS: In both genders, smoking is associated with higher incidence and prevalence rates for HPV infection, whereas the latter responds to a dose-effect relationship. The overall HPV prevalence for smoking patients was 48.2 versus 37. 5 % for nonsmoking patients (p < 0.001) (odds ratio (OR) = 1.5, 95 % confidence interval (CI) 1.4-1.7). Smoking does also increase persistence rates for high-risk HPV infection, while this correlation is debatable for low-risk HPV. The incidence and recurrence rates of anogenital warts are significantly increased in smokers. CONCLUSIONS: Most current data demonstrate an association between smoking, increased anogenital HPV infection, and development of anogenital warts. These data add to the long list of reasons for making smoking cessation a keystone of patient health.
Authors: Anna R Giuliano; Rebecca L Sedjo; Denise J Roe; Robin Harri; Susie Baldwi; Mary R Papenfuss; Martha Abrahamsen; Paula Inserra Journal: Cancer Causes Control Date: 2002-11 Impact factor: 2.506
Authors: Maribel Almonte; Isabel Dos Santos Silva; Akua Asare; Clare Gilham; Alexandra Sargent; Andrew Bailey; Andrew Turner; Mina Desai; Henry C Kitchener; Julian Peto Journal: J Med Virol Date: 2011-04-22 Impact factor: 2.327
Authors: Aline Simen-Kapeu; Guy La Ruche; Vesa Kataja; Merja Yliskoski; Christine Bergeron; Apollinaire Horo; Kari Syrjänen; Seppo Saarikoski; Matti Lehtinen; François Dabis; Annie J Sasco Journal: Cancer Causes Control Date: 2008-09-24 Impact factor: 2.506
Authors: Carrie M Nielson; Robin B Harris; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Roberto Flores; Lauri E Markowitz; Anna R Giuliano Journal: J Infect Dis Date: 2007-09-17 Impact factor: 5.226
Authors: M Davidson; P G Schnitzer; L R Bulkow; A J Parkinson; M L Schloss; M A Fitzgerald; J A Knight; C M Murphy; N B Kiviat; K E Toomey Journal: J Infect Dis Date: 1994-04 Impact factor: 5.226
Authors: Matthew B Schabath; Luisa L Villa; Hui-Yi Lin; William J Fulp; Eduardo Lazcano-Ponce; Jorge Salmerón; Martha E Abrahamsen; Mary R Papenfuss; Manuel Quiterio; Anna R Giuliano Journal: Int J Cancer Date: 2013-11-13 Impact factor: 7.396
Authors: Krzysztof Bartosz Klimiuk; Dawid Krefta; Karol Kołkowski; Karol Flisikowski; Małgorzata Sokołowska-Wojdyło; Łukasz Balwicki Journal: Int J Environ Res Public Health Date: 2022-07-22 Impact factor: 4.614